Nancy Whiting
Director/Board Member en CARIBOU BIOSCIENCES, INC. .
Fortuna: - $ al 31/03/2024
Origen de la red de primer grado Nancy Whiting.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Biotechnology | 18 | |
| Public Company | Biotechnology | 7 | |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Nancy Whiting a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CELGENE | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director of Finance/CFO General Counsel | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Private Equity Investor | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Investor Private Equity Investor | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| ANAPTYSBIO, INC. | Biotechnology | Chairman Founder | |
Calistoga Pharmaceuticals, Inc.
 Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Independa, Inc.
 Independa, Inc. Packaged SoftwareTechnology Services Independa, Inc. provides software-based solution. It allows caregivers and family members to video chat, send Facebook messages and photos, set up appointments and medication reminders, and play games with their older loved ones. The firm also offers blood-pressure monitoring devices, scales and glucometers, and can serve as a door sensor and emergency-alert system. The company was founded by Kian Saneii in 2009 and is headquartered in San Diego, CA. | Packaged Software | Director/Board Member | |
| ANNEXON, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Ignyta Operating, Inc.
 Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Ignyta Operating, Inc. develops molecular diagnostics for cancer and immunology. It is a biotechnology company developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing. The firm's products include TrailblazeDx for RA, TrailblazeTx for RA, TrailblazeDx for SLE, TrailblazePx for SLE and TrailblazeTx for SLE. The company was founded in August 2011 by Jonathan E. Lim and Gary S. Firestein and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
TempestTx, Inc.
 TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Stanford University | College/University | Corporate Officer/Principal Graduate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Director/Board Member | |
| Middlebury College | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| University of California, Irvine | College/University | Undergraduate Degree Graduate Degree | |
Young Womens Christian Association USA
 Young Womens Christian Association USA Services to the Health IndustryHealth Services Young Womens Christian Association USA operates as a multicultural women's organization. It provides shelters, child care, employment training, job placement, and youth development programs for women. The firm also sponsors racial justice, antiviolence, and human rights advocacy programs. Young Women's Christian Association was founded in 1855 and is headquartered in Washington, DC. | Services to the Health Industry | Chief Executive Officer | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| FATE THERAPEUTICS, INC. | Biotechnology | Private Equity Investor Director/Board Member | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
City Hill Ventures LLC
 City Hill Ventures LLC Investment ManagersFinance City Hill Ventures LLC (City Hill Ventures) is a venture capital firm founded in 2010 by Jonathan Lim. The firm is headquartered in San Diego, California. | Investment Managers | Founder Private Equity Investor | |
NuMedii, Inc.
 NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| IGNYTA INC | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| Tufts University School of Medicine | College/University | Doctorate Degree | |
Novome Biotechnologies, Inc.
 Novome Biotechnologies, Inc. BiotechnologyHealth Technology Novome Biotechnologies, Inc. operates as a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The company was founded by William DeLoache, Weston Whitaker, Liz Shepherd and Zachary Russ in 2016 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Aardvark Therapeutics, Inc.
 Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel small molecule therapeutics for obesity and metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Private Equity Investor | |
| METACRINE, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Radionetics Oncology, Inc.
 Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company based in Menlo Park, CA. Radionetics Oncology, Inc. focuses on the discovery and development of novel radiotherapeutics for the treatment of various oncology indications. Radionetics Oncology spun out of Crinetics Pharmaceuticals and is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Investments. The company is advancing a pipeline of small molecule radioligands that target G-protein coupled receptors to treat a wide range of cancers, including adrenocortical carcinoma, breast cancer, and lung cancer. The company's platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes selectively to tumors expressing peptide receptors. The company's pipeline consists of multiple lead drug candidates, and they are conducting additional drug discovery efforts in collaboration with Crinetics Pharmaceuticals. The market for radiopharmaceuticals is expected to rise to $12.6 billion by 2027. The company was founded by Scott R. Struthers, and Paul A. Grayson has been the CEO since 2024. | Pharmaceuticals: Major | Director/Board Member | |
| New York University School of Medicine | College/University | Doctorate Degree | |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | Miscellaneous Commercial Services | Chairman |
Estadísticas
Internacional
| Estados Unidos | 49 |
Sectorial
| Health Technology | 32 |
| Consumer Services | 11 |
| Commercial Services | 4 |
| Finance | 3 |
| Technology Services | 2 |
Operativa
| Director/Board Member | 143 |
| Corporate Officer/Principal | 73 |
| Independent Dir/Board Member | 51 |
| Chief Tech/Sci/R&D Officer | 29 |
| Undergraduate Degree | 27 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Kristina Burow | 40 |
| Carol Gallagher | 39 |
| Liam Ratcliffe | 32 |
| Scott Braunstein | 25 |
| Christine Brennan | 20 |
| Jonathan Lim | 18 |
| Athena Countouriotis | 17 |
| Zachary Hornby | 15 |
| Nicholas B. Lydon | 13 |
| Natalie Sacks | 13 |
| Andrew Guggenhime | 13 |
| Barbara McClung | 12 |
| Dara Richardson-Heron | 11 |
| Timothy Kelly | 9 |
| Syed Rizvi | 9 |
- Bolsa de valores
- Insiders
- Nancy Whiting
- Conexiones Empresas
